Toyota Showcases Hybrid Portfolio at 2015 Atlanta International Auto Show
New Study Comparing ABThera™ to BVPT, Published in the Annals of Surgery, Demonstrated Reduced 90-Day Mortality
Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Executes Securities Purchase Agreement for $2.5 Million Financing and Receives Initial Funding
Research and Markets: Markets For Carbon Nanotubes As Transparent Conductors 2015
Navidea and Norgine Enter European Commercial Partnership for Lymphoseek®; Navidea to Receive $2 Million Upfront Payment
Several recent cases reveal that IRA owners are exposed to IRS scrutiny for alleged IRA errors for a lot longer than they might have thought.
Following the Bobrow Case, the risk of using IRA-to-IRA rollovers (versus direct transfers) is even greater than before.
Supply glut, warm weather, and rock-bottom prices challenge producers.